SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy
Procyon Biopharma Inc.
An SI Board Since August 1998
Posts SubjectMarks Bans Symbol
356 6 0 PBP
Emcee:  thebeach Type:  Unmoderated
Introduction Market Data Compact
A Quebec based bio-pharmaceutical company engaged in the fight for cancer therapies and early detection.
Procyon BioPharma Inc. is a Montreal based cancer
therapeutics company focused on advancing several
platform technologies that have potential to treat,
diagnose and prevent cancer.
procyonbiopharma.com
procyonbiopharma.com
procyonbiopharma.com
procyonbiopharma.com
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
356Procyon Biopharma identifies novel PSP94 binding protein Tuesday October 26, 8:1gg cox-10/26/2004
355Procyon Reports Further Positive Clinical Results with PCK3145 Therapeutthebeach-2/17/2004
354Reuters Procyon Biopharma jumps on U.S. anti-HIV patent thebeach-10/20/2003
353robtv.ca Hans Mader on Tuesday at 8:50 AM on Power Breakfastthebeach-10/7/2003
352Personal Message sent again If you do not receive it, I will post it here. As suncasper-9/30/2003
351Hi thebeach You have PM (personal mail) Please review and respond Cheers SCsuncasper-9/29/2003
350Invitation to Participate in a Conference Call - Procyon to Discuss Interim Phasthebeach-9/28/2003
349On October 1st, Hans J. Mader along with Procyon's Senior Executive Vice- Prthebeach-9/26/2003
348canadanewswire.cathebeach-6/19/2003
347Very interesting feature on Hans Mader and Procyon Biopharma in the Journal de Mthebeach-6/16/2003
346Pharmacor to Join Procyon - Acquisition Expands Drug Candidate Pipeline MONTthebeach-3/28/2003
345As a shareholder of Procyon it saddens me to have to make a stand here on this bthebeach-3/27/2003
344procyonbiopharma.comthebeach-3/24/2003
343canadanewswire.cathebeach-1/16/2003
342Yes it is lonely here but hopefully not for long.Hans and Co. have signed up a vthebeach-12/14/2002
341Hi thebeach, You must feel lonely as the only poster of late. There is more posuncasper-12/14/2002
340$10 million for Procyon - La Financiere du Quebec Makes Its First Biolevier Loanthebeach-12/13/2002
339International Medical Innovations Procyon has entered into a licensing agreementthebeach-11/12/2002
338“This agreement brings all of the relevant technologies and patents under one rothebeach-11/12/2002
337procyonbiopharma.com pressID=66PROCYON BIOPHARMA LICENSES COLORECTAL CANCER SCREthebeach-11/12/2002
336IMI reports development progress on three cancer-detection tests Tuesday Novembethebeach-11/12/2002
335Procyon BioPharma (TSX-PBP) The last three months have been very much maintainithebeach-10/15/2002
334I must agree with the general consensus on this board. Procyon will be one of ththebeach-5/19/2002
333Tuesday April 9, 10:14 am Eastern Time Press Release SOURCE: Procyon Biopharma Ithebeach-4/9/2002
332Wednesday January 9, 11:14 am Eastern Time Press Release SOURCE: Procyon Biophthebeach-1/9/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News